Cargando…

Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer

PAM50 gene expression subtypes represent a cornerstone in the molecular classification of breast cancer and are included in risk prediction models to guide therapy. We aimed to illustrate the impact of included genes and biological processes on subtyping while considering a tumor’s underlying clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veerla, Srinivas, Hohmann, Lennart, Nacer, Deborah F., Vallon-Christersson, Johan, Staaf, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587090/ https://www.ncbi.nlm.nih.gov/pubmed/37857634 http://dx.doi.org/10.1038/s41523-023-00589-0

Ejemplares similares

Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study
por: Nacer, Deborah F., et al.
Publicado: (2023)

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019)

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
por: Holm, Karolina, et al.
Publicado: (2010)

Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
por: Lien, Tonje G., et al.
Publicado: (2021)

Normalization of array-CGH data: influence of copy number imbalances
por: Staaf, Johan, et al.
Publicado: (2007)

SRIQ clustering: A fusion of Random Forest, QT clustering, and KNN concepts
por: Karlström, Jacob, et al.
Publicado: (2022)

Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray
por: Vallon-Christersson, Johan, et al.
Publicado: (2007)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression
por: Kwan, Marilyn L, et al.
Publicado: (2015)

Multi-Omic Regulation of the PAM50 Gene Signature in Breast Cancer Molecular Subtypes
por: Ochoa, Soledad, et al.
Publicado: (2020)

Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios
por: Staaf, Johan, et al.
Publicado: (2008)

Genetic Background May Contribute to PAM50 Gene Expression Breast Cancer Subtype Assignments
por: Hu, Ying, et al.
Publicado: (2013)

Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer
por: Dix-Peek, Thérèse, et al.
Publicado: (2023)

Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
por: Arbajian, Elsa, et al.
Publicado: (2020)

Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2021)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly
por: Aine, Mattias, et al.
Publicado: (2021)

Making Breast Cancer Molecular Subtypes Robust?
por: Staaf, Johan, et al.
Publicado: (2014)

PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
por: Bastien, Roy RL, et al.
Publicado: (2012)

Gene modules associated with breast cancer distant metastasis-free survival in the PAM50 molecular subtypes
por: Liu, Rong, et al.
Publicado: (2016)

Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
por: Staaf, Johan, et al.
Publicado: (2008)

PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
por: Prat, A., et al.
Publicado: (2012)

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
por: Lundgren, Christine, et al.
Publicado: (2022)

How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022)

Calibration and assessment of channel-specific biases in microarray data with extended dynamical range
por: Bengtsson, Henrik, et al.
Publicado: (2004)

Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
por: Hurson, Amber N., et al.
Publicado: (2023)

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
por: Asleh, Karama, et al.
Publicado: (2023)

Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
por: Nacer, Deborah F, et al.
Publicado: (2021)

BASE - 2nd generation software for microarray data management and analysis
por: Vallon-Christersson, Johan, et al.
Publicado: (2009)

Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance
por: Kim, Hee Kyung, et al.
Publicado: (2019)

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
por: Jönsson, Göran, et al.
Publicado: (2010)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

Research-based PAM50 signature and long-term breast cancer survival
por: Pu, Minya, et al.
Publicado: (2019)

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2010)

Radiogenomics analysis reveals the associations of dynamic contrast-enhanced–MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer
por: Ming, Wenlong, et al.
Publicado: (2022)

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review
por: Canino, Fabio, et al.
Publicado: (2022)

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
por: Olsson, Anders, et al.
Publicado: (2010)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
por: Martín, Miguel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oi7llmc0tdmnd91dgqte2kjjnc